e-Drug3D 710 |
ATOVAQUONE
|
cas 95233-18-4 |
CLASS ANTIPARASITIC |
ROUTE (list) ORAL |
PK parameters F 47 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE PROTEIN I, MITOCHONDRIAL (BC1) |
DrugCentral Cytochrome b UNIPROT Q02768 MT-CYB |
Download SDF file | 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione Formula: Calculated chemical properties: MW 366.82 NB_atoms 26 XLogP 5.35 PSA 49.748 NB_HD 1 NB_HA 3 fsp3 0.27 Lipinski(0=no;1=yes) 0 |
FDA NDA 020259 (pdf not found) INN (ATOVAQUONE) MEPRON (GLAXOSMITHKLINE LLC) APPROVAL= AP YEAR= 1992 NEWMOLECULARENTITY DISCONTINUED NDA 020500 (pdf not found) INN (ATOVAQUONE) MEPRON (GLAXOSMITHKLINE LLC) APPROVAL= AP YEAR= 1995 NDA 021078 (pdf not found) INN (ATOVAQUONE ; PROGUANIL HYDROCHLORIDE) MALARONE (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 2000 NDA 091211 (pdf not found) INN (ATOVAQUONE ; PROGUANIL HYDROCHLORIDE) ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2011 NDA 202362 (pdf not found) INN (ATOVAQUONE ; PROGUANIL HYDROCHLORIDE) ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (MYLAN) APPROVAL= AP YEAR= 2014 NDA 202960 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2014 NDA 207833 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (CHARTWELL RX) APPROVAL= AP YEAR= 2017 NDA 209750 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (APOTEX) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 209105 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (LUPIN LTD) APPROVAL= AP YEAR= 2018 NDA 209685 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (GLENMARK SPECLT) APPROVAL= AP YEAR= 2018 NDA 210692 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (HETERO LABS LTD III) APPROVAL= AP YEAR= 2018 NDA 210510 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (ABHAI LLC) APPROVAL= AP YEAR= 2019 NDA 212918 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (BIONPHARMA) APPROVAL= AP YEAR= 2021 NDA 214272 (pdf not found) INN (ATOVAQUONE) ATOVAQUONE (PAI HOLDINGS) APPROVAL= AP YEAR= 2021 |
Other links: |